Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07871604 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis

Study acronym: MINI-STAR
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Yonsei University
239 trials monitored
See 2 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
This study aims to compare the tolerability and metabolic safety of three low-dose statin/ezetimibe combinations (rosuvastatin/ezetimibe 2.5/10 mg, atorvastatin/ezetimibe 5/10 mg, pitavastatin/ezetimibe 1/10 mg) in patients with minimal subclinical atherosclerosis identified by imaging studies (CCTA, CAG, or carotid sonography)
Trial Details
NCT Number NCT07871604
Lead Sponsor Yonsei University
Collaborators: Daewoong Pharmaceutical Co. LTD.
Conditions
(from sponsor)		 Atherosclerosis Cardiovascular Disease
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov